<DOC>
	<DOCNO>NCT01203709</DOCNO>
	<brief_summary>A trial combination two drug treatment refractory lupus nephritis .</brief_summary>
	<brief_title>Low-dose Combination Mycophenolate Mofetil ( MMF ) Tacrolimus ( Tac ) Refractory Lupus Nephritis</brief_title>
	<detailed_description>Low-dose combination mycophenolate mofetil tacrolimus refractory lupus nephritis : 12-month prospective study</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>1 . Active nephritis document renal biopsy within 24 month entry ; 2 . Failure respond 2 immunosuppressive regimen consist highdose prednisolone combine noncorticosteroid immunosuppressive agent together ACE inhibitor plus minus angiotensin receptor blocker ( ARB ) least 4 month regimen maximally tolerate drug dosage ; 3 . Serum creatinine ( Scr ) less 200umol/L . 1 . Previous intolerance either MMF/Tac ; 2 . Scr &gt; 200umol/L ; 3 . Informed consent unavailable .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>lupus</keyword>
	<keyword>nephritis</keyword>
	<keyword>glomerulonephritis</keyword>
	<keyword>nephropathy</keyword>
	<keyword>refractory</keyword>
</DOC>